Pseudocirrhosis in Breast Cancer – Experience From an Academic Cancer Center di Dharmesh Gopalakrishnan, Ain Shajihan, Andrei S. Purysko, Jame Abraham

Testo

Noninvasive prenatal testing detecting metastatic breast cancer: Case report and literature review di Gabriel Francisco Pereira Aleixo, Holly Pederson, Nancy Dalpiaz, Jame Abraham

Testo

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer di Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Amit Gupta, Jame Abraham, Alberto J. Montero, Anant Madabhushi

Testo

Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study. di Alok A Khorana, Katherine Tullio, Paul Elson, Nathan A Pennell, Stephen R Grobmyer, Matthew F Kalady, Daniel Raymond, Jame Abraham, Eric A Klein, R Matthew Walsh, Emily E Monteleone, Wei Wei, Brian Hobbs, Brian J Bolwell

Testo

Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients di Yadi Zhou, Yuan Hou, Muzna Hussain, Sherry‐Ann Brown, Thomas Budd, W. H. Wilson Tang, Jame Abraham, Bo Xu, Chirag Shah, Rohit Moudgil, Zoran Popovic, Leslie Cho, Mohamed Kanj, Chris Watson, Brian Griffin, Mina K. Chung, Samir Kapadia, Lars Svensson, Patrick Collier, Feixiong Cheng

Testo

Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer di Megan L. Kruse, Mona Patel, Jeffrey McManus, Yoon-Mi Chung, Xiuxiu Li, Wei Wei, Peter S. Bazeley, Fumihiko Nakamura, Aimalie Hardaway, Erinn Downs, Sarat Chandarlapaty, Mathew Thomas, Halle C.F. Moore, George T. Budd, W.H. Wilson Tang, Stanley L. Hazen, Aaron Bernstein, Serena Nik-Zainal, Jame Abraham, Nima Sharifi

Testo

Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer di Samuel A. Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J. Montero, Corey Lipchik, Melanie Finnigan, Rachel C. Jankowitz, Mohamad A. Salkeni, Sai K. Maley, Shannon L. Puhalla, Fanny Piette, Katie Quinn, Kyle Chang, Rebecca J. Nagy, Carmen J. Allegra, Kelly Vehec, Norman Wolmark, Peter C. Lucas, Ashok Srinivasan, Katherine L. Pogue-Geile

Testo

NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer di Samuel A. Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J. Montero, Corey Lipchik, Melanie Finnigan, Rachel C. Jankowitz, Mohamad A. Salkeni, Sai K. Maley, Shannon L. Puhalla, Fanny Piette, Katie Quinn, Kyle Chang, Rebecca J. Nagy, Carmen J. Allegra, Kelly Vehec, Norman Wolmark, Peter C. Lucas, Ashok Srinivasan, Katherine L. Pogue-Geile

Testo

Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study di Ilana Schlam, Kelly A. Hirko, Daniela Shveid, Inas Abuali, Sarah Sewaralthahab, Faina Nakhils, Aditi Hazra, Csongor Lengyel, Sara Altuna, Sadaqat Hussain, Fahmi Seid, Sara Jamil, Andrew Odhiambo, Jose Pablo Leone, Otto Metzger, Jame Abraham, Enrique Soto-Perez-de-Celis, Wendy Y. Chen, Caroline Block, Susan Schumer, Jennifer R. Bellon, Carmine Valenza, Giuseppe Curigliano, Sara M. Tolaney, Filipa Lynce, Dario Trapani

Testo

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ br... di Samuel A. Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde, James M. Orcutt, Marina E. Cazzaniga, Fanny Piette, Silvia Antolín, Elena Aguirre, Javier Cortes, Antonio Llombart-Cussac, Serena Di Cosimo, Rim S. Kim, Huichen Feng, Corey Lipchik, Peter C. Lucas, Ashok Srinivasan, Ying Wang, Nan Song, Patrick G. Gavin, April D. Balousek, Soonmyung Paik, Carmen J. Allegra, Norman Wolmark, Katherine L. Pogue-Geile

Testo

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer di Samuel A. Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde, James M. Orcutt, Marina E. Cazzaniga, Fanny Piette, Silvia Antolín, Elena Aguirre, Javier Cortes, Antonio Llombart-Cussac, Serena Di Cosimo, Rim S. Kim, Huichen Feng, Corey Lipchik, Peter C. Lucas, Ashok Srinivasan, Ying Wang, Nan Song, Patrick G. Gavin, April D. Balousek, Soonmyung Paik, Carmen J. Allegra, Norman Wolmark, Katherine L. Pogue-Geile

Testo